Hemodynamic and efficacies of domestic levosimendan versus dobutamine in patients with acute decompensated heart failure

National Medical Journal of China

Volumn 92, Issue 8, 2012, Pages 555-558

  Zhang, Yu Hui ^a   Qing, En Ming ^b   Zhang, Jian ^a   Huang, Yan ^a   Lü, Rong ^a   Zhou, Qiong ^a   Wei, Bing Qi ^a   An, Too ^a   Qing, Ping ^a   Zou, Chang Hong ^a  

^a FUWAI HOSPITAL   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Acute decompensated heart failure; Dobutamine; Hemodynamic; Levosimendan

Indexed keywords

DOBUTAMINE; LEVOSIMENDAN;

ACUTE HEART FAILURE; ADULT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LUNG ARTERY PRESSURE; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SYSTEMIC VASCULAR RESISTANCE;

ADOLESCENT; ADULT; DOBUTAMINE; DOUBLE-BLIND METHOD; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; PYRIDAZINES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867954962     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.08.014     Document Type: Article

References (8)

1. Rognoni A, Lupi A, Lazzero M, et al. Levosimendan: from basic science to clinical trials. Recent Pat Cardiovasc Drug Discov, 2011, 6:9-15.
2. Mebazaa A, Nieminen M, Packer M, et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial. JAMA, 2007, 297:1883-1891.
3. Krell M J, Kline E M, Bates E R, et al. Intermittent, ambulatory dobutamine infusion in severe heart failure. Am Heart J, 1986, 112:787-791.
4. Moiseyev V S, Poder P, Andrejevs N, et al. Safety and efficacy of a novel calcium sensitizer, levosimendan in patients with left ventricular failure due to an acute myocardial infarction: a randomized, placebo-controlled, double-blind study (RUSSLAN). Eur Heart J, 2002, 23:1422-1432.
5. Follath F, Cleland J G, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet, 2002, 360:196-202.
6. Parissis J T, Paraskevaidis I, Bistola V, et al. Effects of levosimendan on right ventricular function in patients with advanced heart failure. Am J Cardiol, 2006, 98:1489-1492.
7. Bergh C H, Andersson B, Dahlström U, et al. Intravenous levosimendan vs dobutamine in acute decompensated heart failure patients on beta-blockers. Eur J Heart Failure, 2010, 12: 404-410.
8. Nieminen M S, Akkila J, Hasenfuss G. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol, 2000, 36:1903-1912.